Pharma Mar, S.A. (BME:PHM)
Spain flag Spain · Delayed Price · Currency is EUR
96.25
-0.05 (-0.05%)
May 18, 2026, 4:23 PM CET

Pharma Mar Company Description

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally.

The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer; Aplidin for treating multiple myeloma; and Zepzelca for treating patients with small cell lung cancer.

The company also develops PM14 which is in phase II clinical trails for the treatment of solid tumors.

In addition, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression.

The company was incorporated in 1986 and is based in Madrid, Spain.

Pharma Mar, S.A.
Pharma Mar logo
CountrySpain
Founded1986
IndustryBiotechnology
SectorHealthcare
Employees505
CEOJose Fernandez Sousa-Faro

Contact Details

Address:
Avenida de los Reyes, 1
Madrid
Spain
Phone34 91 846 60 00

Stock Details

Ticker SymbolPHM
ExchangeMadrid Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyEUR
ISIN NumberES0169501022
SIC Code2836

Key Executives

NamePosition
Jose Maria Fernandez Sousa-Faro Ph.D.Founder, Executive Chairman, Chief Executive Officer and President
Pedro Francisco Fernandez PuentesExecutive Vice-Chairman
Juan Carlos-Torres CarreteroFounder
María Luisa de Francia CaballeroChief Financial Officer
José Luis Moreno Martinez-LosaHead of Capital Markets and Investor Relations
Juan Gomez PulidoGeneral Counsel and Secretary of the Board of Directors
Sandra Llamera SanchezGlobal Compliance Head
Lara VadilloCommunication Director
Belén Sopesén Veramendi Ph.D.Director of Corporate Development
Luis Rupérez CuencaDirector of Human Resources and IT